GlaxoSmithKline Pharmaceuticals Net Sales Up 10%, PBT Grows by 17% in Second Quarter of FY 2009  

Mumbai, Maharashtra, India, Monday, July 27, 2009 -- (Business Wire India)

GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the second quarter ended 30th June 2009. The Company has posted a Net Sales growth of 10% compared to the previous quarter, while Profit Before Tax has grown by 17%, on a comparable basis.

Commenting on the performance during the quarter, Dr. Hasit B. Joshipura, Managing Director, said, “The Company’s products during the quarter have achieved market competitive growth. Recent new launches including Arixtra, the antithrombotic agent, Rotarix, the rotavirus diarrhea vaccine and Tykerb for refractory breast cancer are all tracking ahead of plan”.

About GlaxoSmithKline:

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk-india.com.

To view the Unaudited Financial Results for the Quarter and Half Year Ended 30th June, 2009, please click on the link given below:

Unaudited Financial Results for the Quarter and Half Year Ended 30th June, 2009